BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29187443)

  • 1. Total Knockdown of LMW-PTP in MDA-MB-231 Cells Reduces Osteoclastogenesis.
    Sapinho G; Alho I; Bicho M; Coelho C
    Anticancer Res; 2017 Dec; 37(12):6671-6677. PubMed ID: 29187443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Molecular Weight Protein Tyrosine Phosphatase Slow Isoform Knockdown in MDA-MB-435 Cells Decreases RAW 264.7 Osteoclastic Differentiation.
    Alho I; Costa L; Bicho M; Coelho C
    Anticancer Res; 2016 May; 36(5):2227-32. PubMed ID: 27127127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of low molecular weight protein tyrosine phosphatase isoforms in human breast cancer epithelial cell lines.
    Alho I; Costa L; Bicho M; Coelho C
    Anticancer Res; 2013 May; 33(5):1983-7. PubMed ID: 23645747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low molecular weight protein tyrosine phosphatase isoforms regulate breast cancer cells migration through a RhoA dependent mechanism.
    Alho I; Costa L; Bicho M; Coelho C
    PLoS One; 2013; 8(9):e76307. PubMed ID: 24086724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible mechanism of low molecular weight protein tyrosine phosphatase (LMW-PTP) activity modulation by glutathione action during human osteoblast differentiation.
    de Souza Malaspina TS; Zambuzzi WF; dos Santos CX; Campanelli AP; Laurindo FR; Sogayar MC; Granjeiro JM
    Arch Oral Biol; 2009 Jul; 54(7):642-50. PubMed ID: 19414171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast adhesion dynamics: a possible role for ROS and LMW-PTP.
    Fernandes GV; Cavagis AD; Ferreira CV; Olej B; Leão Mde S; Yano CL; Peppelenbosch M; Granjeiro JM; Zambuzzi WF
    J Cell Biochem; 2014 Jun; 115(6):1063-9. PubMed ID: 24123071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems.
    Liverani C; Mercatali L; Spadazzi C; La Manna F; De Vita A; Riva N; Calpona S; Ricci M; Bongiovanni A; Gunelli E; Zanoni M; Fabbri F; Zoli W; Amadori D; Ibrahim T
    Bone; 2014 Sep; 66():214-22. PubMed ID: 24956020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers.
    Malentacchi F; Marzocchini R; Gelmini S; Orlando C; Serio M; Ramponi G; Raugei G
    Biochem Biophys Res Commun; 2005 Sep; 334(3):875-83. PubMed ID: 16036221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
    Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE
    J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LMW-PTP is a positive regulator of tumor onset and growth.
    Chiarugi P; Taddei ML; Schiavone N; Papucci L; Giannoni E; Fiaschi T; Capaccioli S; Raugei G; Ramponi G
    Oncogene; 2004 May; 23(22):3905-14. PubMed ID: 15021900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation.
    Chiarugi P; Fiaschi T; Taddei ML; Talini D; Giannoni E; Raugei G; Ramponi G
    J Biol Chem; 2001 Sep; 276(36):33478-87. PubMed ID: 11429404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts.
    Grano M; Mori G; Minielli V; Cantatore FP; Colucci S; Zallone AZ
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1097-100. PubMed ID: 10772956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase.
    Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G
    Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesis.
    Alho I; Costa L; Bicho M; Coelho C
    Tumour Biol; 2013 Aug; 34(4):1979-89. PubMed ID: 23584899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase LMW-PTP exhibits distinct roles between vascular endothelial and smooth muscle cells.
    Shimizu H; Toyama O; Shiota M; Kim-Mitsuyama S; Miyazaki H
    J Recept Signal Transduct Res; 2005; 25(1):19-33. PubMed ID: 15960392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morin-dependent inhibition of low molecular weight protein tyrosine phosphatase (LMW-PTP) restores sensitivity to apoptosis during colon carcinogenesis: Studies in vitro and in vivo, in an Apc-driven model of colon cancer.
    Lori G; Paoli P; Femia AP; Pranzini E; Caselli A; Tortora K; Romagnoli A; Raugei G; Caderni G
    Mol Carcinog; 2019 May; 58(5):686-698. PubMed ID: 30582224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphisms of low molecular weight protein tyrosine phosphatase (LMW-PTP): relationship with erythrocyte enzymatic phenotype in patients with Systemic Lupus Erythematosus].
    Esteves Martins Mde F; Carvalho R; Alves M; Monteiro da Silva Ferreira CA; Pires Bicho MD
    Acta Reumatol Port; 2008; 33(2):177-87. PubMed ID: 18604186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of the apo form and a complex of human LMW-PTP with a phosphonic acid provide new evidence of a secondary site potentially related to the anchorage of natural substrates.
    Fonseca EMB; Trivella DBB; Scorsato V; Dias MP; Bazzo NL; Mandapati KR; de Oliveira FL; Ferreira-Halder CV; Pilli RA; Miranda PCML; Aparicio R
    Bioorg Med Chem; 2015 Aug; 23(15):4462-4471. PubMed ID: 26117648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight protein-tyrosine phosphatase is involved in growth inhibition during cell differentiation.
    Fiaschi T; Chiarugi P; Buricchi F; Giannoni E; Taddei ML; Talini D; Cozzi G; Zecchi-Orlandini S; Raugei G; Ramponi G
    J Biol Chem; 2001 Dec; 276(52):49156-63. PubMed ID: 11595742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abundance of low molecular weight phosphotyrosine protein phosphatase in the nerve-ending fraction in the brain.
    Tanino H; Yoshida J; Yamamoto R; Kobayashi Y; Shimohama S; Fujimoto S
    Biol Pharm Bull; 1999 Aug; 22(8):794-8. PubMed ID: 10480315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.